Literature DB >> 29551319

The Impact of Maternal Antibiotics on Neonatal Disease.

Benjamin D Reed1, Kurt R Schibler2, Hitesh Deshmukh1, Namasivayam Ambalavanan3, Ardythe L Morrow4.   

Abstract

OBJECTIVES: We examined the impact of prenatal exposure to maternal antibiotics on risk of necrotizing enterocolitis (NEC), late onset sepsis (LOS), and death in infants born preterm. STUDY
DESIGN: Secondary data analysis was conducted via an extant cohort of 580 infants born <32 weeks of gestation and enrolled in 3 level III neonatal intensive care units. Prenatal antibiotic exposure was defined as antibiotics received by the mother within 72 hours before delivery. Postnatal empiric antibiotic exposure was defined as antibiotic initiated within the first day of life without documented infection, categorized as low (<5 days) or high (>5 days) duration.
RESULTS: Two-thirds of mothers received antibiotics within 72 hours before delivery, of whom 59.8% received >1 antibiotic. Ampicillin (37.6%) and azithromycin (26.4%) were the most common antibiotics given. NEC occurred in 7.5%, LOS in 11.1%, death in 9.6%, and the combined outcome of NEC, LOS, or death in 21.3% of study infants. In multiple logistic regression models adjusted for gestational age, postnatal empiric antibiotic exposure, and other factors, prenatal antibiotic exposure was associated with reduced risk of NEC (OR 0.28; 95% CI 0.14-0.56; P < .001), death (OR 0.29; 95% CI 0.14-0.60; P = .001), but not LOS (OR 1.59; 95% CI 0.84-2.99; P = .15), although protection was significant for the combined outcome (OR 0.52, P < .001). High postnatal empiric antibiotic exposure was associated with greater risk of death but not other outcomes in multiple regression models (OR 3.18, P = .002).
CONCLUSIONS: Prenatal antibiotic exposure was associated with lower rates of NEC or death of infants born preterm, and its impact on infant outcomes warrants further study.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  empiric antibiotics; infant born preterm; late-onset sepsis; necrotizing enterocolitis

Mesh:

Substances:

Year:  2018        PMID: 29551319      PMCID: PMC6028045          DOI: 10.1016/j.jpeds.2018.01.056

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  29 in total

1.  Are we using too many antibiotics during pregnancy?

Authors:  W J Ledger; M J Blaser
Journal:  BJOG       Date:  2013-11       Impact factor: 6.531

2.  The maternal microbiota drives early postnatal innate immune development.

Authors:  Mercedes Gomez de Agüero; Stephanie C Ganal-Vonarburg; Tobias Fuhrer; Sandra Rupp; Yasuhiro Uchimura; Hai Li; Anna Steinert; Mathias Heikenwalder; Siegfried Hapfelmeier; Uwe Sauer; Kathy D McCoy; Andrew J Macpherson
Journal:  Science       Date:  2016-03-18       Impact factor: 47.728

3.  Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics.

Authors:  Capucine Didier; Marie-Pierre Streicher; Didier Chognot; Raphaèle Campagni; Albert Schnebelen; Jean Messer; Lionel Donato; Bruno Langer; Nicolas Meyer; Dominique Astruc; Pierre Kuhn
Journal:  Eur J Pediatr       Date:  2011-12-02       Impact factor: 3.183

4.  Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants.

Authors:  Venkata S Kuppala; Jareen Meinzen-Derr; Ardythe L Morrow; Kurt R Schibler
Journal:  J Pediatr       Date:  2011-07-23       Impact factor: 4.406

5.  Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis.

Authors:  Matthew J Bizzarro; Louise-Marie Dembry; Robert S Baltimore; Patrick G Gallagher
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

6.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.

Authors:  Barbara J Stoll; Nellie I Hansen; Edward F Bell; Michele C Walsh; Waldemar A Carlo; Seetha Shankaran; Abbot R Laptook; Pablo J Sánchez; Krisa P Van Meurs; Myra Wyckoff; Abhik Das; Ellen C Hale; M Bethany Ball; Nancy S Newman; Kurt Schibler; Brenda B Poindexter; Kathleen A Kennedy; C Michael Cotten; Kristi L Watterberg; Carl T D'Angio; Sara B DeMauro; William E Truog; Uday Devaskar; Rosemary D Higgins
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

7.  Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants.

Authors:  Ardythe L Morrow; Anne J Lagomarcino; Kurt R Schibler; Diana H Taft; Zhuoteng Yu; Bo Wang; Mekibib Altaye; Michael Wagner; Dirk Gevers; Doyle V Ward; Michael A Kennedy; Curtis Huttenhower; David S Newburg
Journal:  Microbiome       Date:  2013-04-16       Impact factor: 14.650

8.  Intestinal microbiota of preterm infants differ over time and between hospitals.

Authors:  Diana H Taft; Namasivayam Ambalavanan; Kurt R Schibler; Zhuoteng Yu; David S Newburg; Doyle V Ward; Ardythe L Morrow
Journal:  Microbiome       Date:  2014-10-01       Impact factor: 14.650

9.  The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice.

Authors:  Hitesh S Deshmukh; Yuhong Liu; Ogechukwu R Menkiti; Junjie Mei; Ning Dai; Claire E O'Leary; Paula M Oliver; Jay K Kolls; Jeffrey N Weiser; G Scott Worthen
Journal:  Nat Med       Date:  2014-04-20       Impact factor: 53.440

10.  Early Gut Microbiota Perturbations Following Intrapartum Antibiotic Prophylaxis to Prevent Group B Streptococcal Disease.

Authors:  Giuseppe Mazzola; Kiera Murphy; R Paul Ross; Diana Di Gioia; Bruno Biavati; Luigi T Corvaglia; Giacomo Faldella; Catherine Stanton
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

View more
  5 in total

Review 1.  A critical analysis of risk factors for necrotizing enterocolitis.

Authors:  Allison Thomas Rose; Ravi Mangal Patel
Journal:  Semin Fetal Neonatal Med       Date:  2018-08-01       Impact factor: 3.926

2.  Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis.

Authors:  Jeffrey R Singer; Emily G Blosser; Carlene L Zindl; Daniel J Silberger; Sean Conlan; Vincent A Laufer; Daniel DiToro; Clay Deming; Ranjit Kumar; Casey D Morrow; Julia A Segre; Michael J Gray; David A Randolph; Casey T Weaver
Journal:  Nat Med       Date:  2019-11-07       Impact factor: 53.440

3.  Uncertainties in Screening and Prevention of Group B Streptococcus Disease.

Authors:  Kirsty Le Doare; Paul T Heath; Jane Plumb; Natalie A Owen; Peter Brocklehurst; Lucy C Chappell
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

4.  Antenatal Antibiotic Exposure Affects Enteral Feeding, Body Growth, and Neonatal Infection in Preterm Infants: A Retrospective Study.

Authors:  Ping Luo; Kun Zhang; You Chen; Xiuwen Geng; Tong Wu; Li Li; Ping Zhou; Ping-Ping Jiang; Liya Ma
Journal:  Front Pediatr       Date:  2021-12-22       Impact factor: 3.418

5.  Maternal Antibiotic Treatment Disrupts the Intestinal Microbiota and Intestinal Development in Neonatal Mice.

Authors:  Chung-Ming Chen; Hsiu-Chu Chou; Yu-Chen S H Yang
Journal:  Front Microbiol       Date:  2021-06-04       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.